Chat with us, powered by LiveChat
4th New Product Planning Summit - Revere Hotel Boston Common

4th New Product Planning Summit
December 2–3, 2019
Revere Hotel Boston Common
Boston, MA

Improve early stage decision-making, optimize lifecycle management, and tailor product plans to ensure the successful commercialization of new drugs

Agenda – 4th New Product Planning Summit



Main Conference Day One

 Monday, December 2

 

4th New Product Planning Summit

9:00 – 9:15
Chairperson’s Opening Remarks

Tony Russell, Executive Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:15 – 10:00
Why New Product Planning Fails (More Often Than It Succeeds) and the Fix!

Paul Harney, President, North America, PRESCIENT HEALTHCARE GROUP
Debasish Talukdar, Global Head of Advisory, PRESCIENT HEALTHCARE GROUP

10:00 – 10:45
Interactive Group Discussion

Tony Russell, Executive Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

Multi-Stakeholder Commercial Model Summit

9:00 – 9:15
Chairperson’s Opening Remarks

Fasiha Haq, Global Medical Education Advisor, Executive-Level Strategy and Execution, ELI LILLY AND COMPANY

9:15 – 10:00
Keynote: Challenges and Opportunities for Stakeholder Collaboration

Fasiha Haq, Global Medical Education Advisor, Executive-Level Strategy and Execution, ELI LILLY AND COMPANY
Maureen McKenna, Business Mentor, Certified Management Consultant, RETURN ON ENERGY

10:00 – 10:45
Use Data Analytics to Improve Commercial Structure and Value-Based Contracting

John Doyle, Ph.D., Vice President, Global Healthcare Innovation Lead, PFIZER

 

10:45 – 11:15

Networking Break


 

11:15 – 12:00
Keep Pace With New Paradigms in Oncology

Alexander Brown, Global Head, New Product Planning Oncology, SANOFI

12:00 – 12:45
Gene Therapy Is a Reality – Now How Do We Successfully Commercialize It?

Parag V. Meswani, Pharm.D, SVP, Commercial Strategy and Operations, AXOVANT SCIENCES

11:15 – 12:00
Value-Based Purchasing and the Conundrum of Government Policy

Tamar Thompson, Head, Federal Executive Branch Strategy and State Government Affairs, BRISTOL-MYERS SQUIBB

12:00 – 12:45
Aligning Internal Capabilities With External Drivers

Michael J. Ruggiero, Senior Vice President, Global Healthcare Policy and External Affairs, CSL BEHRING

 

12:45 – 1:45

Luncheon


 

1:45 – 2:30
Early Stage Target Product Profiles (TPPs) and Opportunity Valuations

Réka Shinkle, Vice President, Commercial and Portfolio Planning, REGENXBIO

2:30 – 3:15
Early Integrated New Product Planning Leads to Launch Success

Anne Marie Robertson, Vice President, Onivyde Marketing, North American Commercial Operations, IPSEN BIOPHARMACEUTICALS

2:30 – 3:15
Determine the Future of Patient Consumerism and the Role of Biopharma Companies

Doug Stover, Former Vice President, Global Head of Patient Experience and Technology Practice, UCB

 

3:15 – 3:45

Networking Break


 

3:45 – 4:30
Building a Strong Foundation: Disease Area Strategy

Katja Wachtendonk, Senior Director, Global New Product Planning, NOVARTIS

4:30 – 5:15
Market Maps: Driving Disproportionate Growth Through Identifying Where and How to Compete

Elaine Hughes, MBA, Executive Director, Commercial Development, CELGENE

3:45 – 4:30
Panel: Commercial Models Strategies Across Different-Sized Companies

Ross Youngs, Chief Executive Officer, BIOSORTIA PHARMACEUTICALS
Raquel Cabo, Vice President, Global Market Access, OVID THERAPEUTICS
Jennifer Muszik, U.S. Commercial Learning Lead, BIOGEN


Main Conference Day Two

 Tuesday, December 3

8:45 – 9:00

Introduction From Co-Chairs


Michael J. Ruggiero, Senior Vice President, Global Healthcare Policy and External Affairs, CSL BEHRING
Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:45 – 10:30

Plan for Value and Access on Both Sides of the Pond


Arup Pramanik, M.D., M.Sc., Vice President, Market Access and Strategy, INDIVIOR

10:30 – 11:00

Networking Break


11:00 – 11:45

Panel: When Do You Incorporate Market Access Considerations into Product Commercialization?


Nayahmka McGriff-Lee, Product and Portfolio Strategy Director, Early Pipeline and Portfolio Strategy, GSK
Arup Pramanik, M.D., M.Sc., Vice President, Market Access and Strategy, INDIVIOR

11:45 – 12:30

Aligning Internal Teams to Ensure Success in New Product Planning and Launches


Michael P. Bentivegna, Vice President, Commercial Development and Lifecycle Innovation, ZOETIS

12:30 – 1:30

Luncheon


 

4th New Product Planning Summit

1:30 – 2:15
Develop a “Glocal” Commercialization Strategy


Christine Leighland, Head, New Product Planning, BIOGEN CANADA


2:15 – 3:00
New and Approved! Strategic Considerations for Effectively Launching a New Indication for a Marketed Drug

Eric Gornstein, Head of New Product Planning, TALARIS THERAPEUTICS

3:00 – 3:45
How and When to Kill a Program in New Product Planning

Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

Multi-Stakeholder Commercial Model Summit

1:30 – 2:15
Keynote: “Can We Talk” Campaign: Taking Action to put Patients’ Priorities at the Heart of Health Care

Rebecca Kirch, Executive VP, Healthcare Quality and Value, NATIONAL PATIENT ADVOCATE FOUNDATION
Melissa Williams, Manager of Health Care Policy and Advocacy, NATIONAL PATIENT ADVOCATE FOUNDATION

2:15 – 3:00
Build a Successful, Modern Model for Access, Advocacy, and Patient Support

Christopher Mancill, Senior Vice President, Market Access and Policy, MORPHOSYS

3:00 – 3:45
Setting Up and Optimizing an Engagement Plan to Provide Maximum Value in a Disease-State Ecosystem

Robert Metz, Senior Vice President, Global Business Operations and External Affairs, HORIZON THERAPEUTICS

 


live chat software